{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:01:47Z","timestamp":1779159707252,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,15]]},"DOI":"10.7759\/cureus.52308","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T15:43:40Z","timestamp":1705333420000},"source":"Crossref","is-referenced-by-count":7,"title":["A Narrative Review of Retinopathy in Diabetic Patients"],"prefix":"10.7759","author":[{"given":"Somya","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana R","family":"Thool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild S","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27:1047-53. 10.2337\/diacare.27.5.1047","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.1.4.252","article-title":"Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973","volume":"1","author":"Pirart J","year":"1978","unstructured":"Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978, 1:252-63. 10.2337\/diacare.1.4.252","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.08.016","article-title":"Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study","volume":"117","author":"Nguyen QD","year":"2010","unstructured":"Nguyen QD, Shah SM, Khwaja AA, et al.. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology. 2010, 117:2146-51. 10.1016\/j.ophtha.2010.08.016","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070010250031","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more","volume":"107","author":"Klein R","year":"1989","unstructured":"Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol. 1989, 107:244-9. 10.1001\/archopht.1989.01070010250031","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","unstructured":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020. the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021, 9:e144-60. 10.1016\/S2214-109X(20)30489-7","journal-title":"Lancet Glob Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.12.019","article-title":"Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality","volume":"128","author":"Modjtahedi BS","year":"2021","unstructured":"Modjtahedi BS, Wu J, Luong TQ, Gandhi NK, Fong DS, Chen W. Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality. Ophthalmology. 2021, 128:1169-79. 10.1016\/j.ophtha.2020.12.019","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson CP","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE, et al.. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003, 110:1677-82. 10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0961-6","article-title":"Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group","volume":"34","author":"Amoaku WM","year":"2020","unstructured":"Amoaku WM, Ghanchi F, Bailey C, et al.. Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. Eye (Lond). 2020, 34:1-51. 10.1038\/s41433-020-0961-6","journal-title":"Eye (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau JW","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R, et al.. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012, 35:556-64. 10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan DM","year":"1993","unstructured":"Nathan DM, Genuth S, Lachin J, et al.. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329:977-86. 10.1056\/NEJM199309303291401","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.00789.x","article-title":"Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold","volume":"60","author":"Chaturvedi N","year":"2001","unstructured":"Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH. Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int. 2001, 60:219-27. 10.1046\/j.1523-1755.2001.00789.x","journal-title":"Kidney Int"},{"key":"ref12","article-title":"Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group","volume":"46","year":"1997","unstructured":"Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1997, 46.1829-39.","journal-title":"Diabetes"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.11.017","article-title":"Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema","volume":"137","author":"Gupta A","year":"2004","unstructured":"Gupta A, Gupta V, Thapar S, Bhansali A. Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. Am J Ophthalmol. 2004, 137:675-82. 10.1016\/j.ajo.2003.11.017","journal-title":"Am J Ophthalmol"},{"key":"ref14","article-title":"Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18","volume":"39","author":"Davis MD","year":"1998","unstructured":"Davis MD, Fisher MR, Gangnon RE, et al.. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998, 39:233-52.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(94)31354-6","article-title":"The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision","volume":"101","author":"Klein R","year":"1994","unstructured":"Klein R, Klein BE, Jensen SC, Moss SE. The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology. 1994, 101:68-76. 10.1016\/s0161-6420(94)31354-6","journal-title":"Ophthalmology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.1.34","article-title":"Effect of pregnancy on progression of diabetic retinopathy","volume":"13","author":"Klein BE","year":"1990","unstructured":"Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990, 13:34-40. 10.2337\/diacare.13.1.34","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.64.6.398","article-title":"Diabetic retinopathy in pregnancy: a 12-year prospective survey","volume":"64","author":"Horvat M","year":"1980","unstructured":"Horvat M, Maclean H, Goldberg L, Crock GW. Diabetic retinopathy in pregnancy: a 12-year prospective survey. Br J Ophthalmol. 1980, 64:398-403. 10.1136\/bjo.64.6.398","journal-title":"Br J Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(78)35693-1","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings","volume":"85","year":"1978","unstructured":"Photocoagulation treatment of proliferative diabetic retinopathy. the second report of diabetic retinopathy study findings. Ophthalmology. 1978, 85:82-106. 10.1016\/s0161-6420(78)35693-1","journal-title":"Ophthalmology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/801269","article-title":"Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets","volume":"2014","author":"Safi SZ","year":"2014","unstructured":"Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS. Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 2014, 2014:801269. 10.1155\/2014\/801269","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2007.s99","article-title":"Diabetic retinopathy","volume":"26 Suppl 1","author":"Fong DS","year":"2003","unstructured":"Fong DS, Aiello L, Gardner TW, et al.. Diabetic retinopathy. Diabetes Care. 2003, 26 Suppl 1:S99-S102. 10.2337\/diacare.26.2007.s99","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee M","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001, 414:813-20. 10.1038\/414813a","journal-title":"Nature"},{"key":"ref22","article-title":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","unstructured":"Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991, 98.766-85.","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01522-2","article-title":"The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography","volume":"134","author":"Lin DY","year":"2002","unstructured":"Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002, 134:204-13. 10.1016\/s0002-9394(02)01522-2","journal-title":"Am J Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.02.004","article-title":"Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology","volume":"111","author":"Williams GA","year":"2004","unstructured":"Williams GA, Scott IU, Haller JA, Maguire AM, Marcus D, McDonald HR. Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology. Ophthalmology. 2004, 111:1055-62. 10.1016\/j.ophtha.2004.02.004","journal-title":"Ophthalmology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/1573405611666150929234644","article-title":"Computer aided systems for diabetic retinopathy detection using digital fundus images: a survey","volume":"12","author":"Qureshi I","unstructured":"Qureshi I, Sharif M, Yasmin M, et al.. Computer aided systems for diabetic retinopathy detection using digital fundus images: a survey. Current Medical Imaging. 12:234-41. 10.2174\/1573405611666150929234644","journal-title":"Current Medical Imaging"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2016.10.001","article-title":"A review on automatic analysis techniques for color fundus photographs","volume":"14","author":"Besenczi R","year":"2016","unstructured":"Besenczi R, T\u00f3th J, Hajdu A. A review on automatic analysis techniques for color fundus photographs. Comput Struct Biotechnol J. 2016, 14:371-84. 10.1016\/j.csbj.2016.10.001","journal-title":"Comput Struct Biotechnol J"},{"key":"ref27","unstructured":"Diabetic Retinopathy Study (DRS). (2006). Accessed. June 4, 2023: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00000160.."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0131","article-title":"Proliferative diabetic retinopathy","volume":"84","author":"Besirli CG","year":"2009","unstructured":"Besirli CG, Johnson MW. Proliferative diabetic retinopathy. Mayo Clin Proc. 2009, 84:1054. 10.4065\/mcp.2009.0131","journal-title":"Mayo Clin Proc"},{"key":"ref29","article-title":"Diabetic retinopathy: an update","volume":"56","author":"Singh R","year":"2008","unstructured":"Singh R, Ramasamy K, Abraham C, Gupta V, Gupta A. Diabetic retinopathy: an update. Indian J Ophthalmol. 2008, 56:179-88.","journal-title":"Indian J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(00)00304-3","article-title":"Diabetes and retinopathy","volume":"107","author":"Vander JF","year":"2000","unstructured":"Vander JF, Ho AC, McNamara JA, et al.. Diabetes and retinopathy. Ophthalmology. 2000, 107:2120-1. 10.1016\/s0161-6420(00)00304-3","journal-title":"Ophthalmology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(97)84041-6","article-title":"Vitreous hemorrhage","volume":"42","author":"Spraul CW","year":"1997","unstructured":"Spraul CW, Grossniklaus HE. Vitreous hemorrhage. Surv Ophthalmol. 1997, 42:3-39. 10.1016\/s0039-6257(97)84041-6","journal-title":"Surv Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello LP","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, et al.. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994, 331:1480-7. 10.1056\/NEJM199412013312203","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0807","article-title":"VEGF164 is proinflammatory in the diabetic retina","volume":"44","author":"Ishida S","year":"2003","unstructured":"Ishida S, Usui T, Yamashiro K, et al.. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003, 44:2155-62. 10.1167\/iovs.02-0807","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321807","article-title":"Prevention and treatment of the complications of diabetes mellitus","volume":"332","author":"Clark CM Jr","year":"1995","unstructured":"Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med. 1995, 332:1210-7. 10.1056\/NEJM199505043321807","journal-title":"N Engl J Med"},{"key":"ref35","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352.837-53.","journal-title":"Lancet"},{"key":"ref36","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group","volume":"317","year":"1998","unstructured":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998, 317:703-13.","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew EY","year":"2010","unstructured":"Chew EY, Ambrosius WT, Davis MD, et al.. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010, 363:233-44. 10.1056\/NEJMoa1001288","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101307010004","article-title":"Diabetic retinopathy and VEGF","volume":"7","author":"Gupta N","year":"2013","unstructured":"Gupta N, Mansoor S, Sharma A, et al.. Diabetic retinopathy and VEGF. Open Ophthalmol J. 2013, 7:4-10. 10.2174\/1874364101307010004","journal-title":"Open Ophthalmol J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.10.2603","article-title":"Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy","volume":"52","author":"Kitada M","year":"2003","unstructured":"Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes. 2003, 52:2603-14. 10.2337\/diabetes.52.10.2603","journal-title":"Diabetes"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.9.1414","article-title":"Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections","volume":"21","author":"King H","year":"1998","unstructured":"King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998, 21:1414-31. 10.2337\/diacare.21.9.1414","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.10.1899","article-title":"Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox","volume":"48","author":"Duh E","year":"1999","unstructured":"Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes. 1999, 48:1899-906. 10.2337\/diabetes.48.10.1899","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti DA","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012, 366:1227-39. 10.1056\/NEJMra1005073","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1904","article-title":"Are individuals with diabetes seeing better?: a long-term epidemiological perspective","volume":"59","author":"Klein R","year":"2010","unstructured":"Klein R, Klein BE. Are individuals with diabetes seeing better?: a long-term epidemiological perspective. Diabetes. 2010, 59:1853-60. 10.2337\/db09-1904","journal-title":"Diabetes"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2171","article-title":"Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010","volume":"39","author":"Leasher JL","year":"2016","unstructured":"Leasher JL, Bourne RR, Flaxman SR, et al.. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care. 2016, 39:1643-9. 10.2337\/dc15-2171","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183642-a-narrative-review-of-retinopathy-in-diabetic-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:19Z","timestamp":1707509659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183642-a-narrative-review-of-retinopathy-in-diabetic-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.52308","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,15]]}}}